홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl → N,N-Diethyl-2-(4-{2-fluoro-4-[2-oxo-2-(2-phenyl-piperidin-1-yl)-ethyl]-phenyl}-piperazin-1-yl)-2-phenyl-acetamide

HRID 1927634
노트
인쇄 미리보기

반응식

HRID 1927634 반응식
Cl[C:2]1[CH:7]=[CH:6][C:5]([CH2:8][C:9]([N:11]2[CH2:16][CH2:15][CH2:14][CH2:13][CH:12]2[C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)=[O:10])=[CH:4][C:3]=1[F:23].[CH2:24]([N:26]([CH2:42][CH3:43])[C:27](=[O:41])[CH:28]([C:35]1[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=1)[N:29]1[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]1)[CH3:25].CC(C1C=C(C(C)C)C(C2C=CC=CC=2P(C2CCCCC2)C2CCCCC2)=C(C(C)C)C=1)C.CC(C)([O-])C.[Na+]>C1(C)C=CC=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH2:42]([N:26]([CH2:24][CH3:25])[C:27](=[O:41])[CH:28]([N:29]1[CH2:34][CH2:33][N:32]([C:2]2[CH:7]=[CH:6][C:5]([CH2:8][C:9](=[O:10])[N:11]3[CH2:16][CH2:15][CH2:14][CH2:13][CH:12]3[C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)=[CH:4][C:3]=2[F:23])[CH2:31][CH2:30]1)[C:35]1[CH:40]=[CH:39][CH:38]=[CH:37][CH:36]=1)[CH3:43]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 111557942-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 23676156Sodium t-butoxideHCID 66663821N,N-diethyl-2-phenyl-2-piperazin-1-yl-acetamideHCID 693044472-(4-Chloro-3-fluoro-phenyl)-1-(2-phenyl-piperidin-1-yl)-ethanone

생성물 1

HCID 58870682N,N-Diethyl-2-(4-{2-fluoro-4-[2-oxo-2-(2-phenyl-piperidin-1-yl)-ethyl]-phenyl}-piperazin-1-yl)-2-phenyl-acetamide
수율 16.4%

시약·촉매·용매 2

HCID 9811564Bis(dibenzylideneacetone)palladium촉매HCID 1140Toluene용매

실험 절차

A solution of 2-(4-chloro-3-fluoro-phenyl)-1-(2-phenyl-piperidin-1-yl)-ethanone (0.25 g, 0.75 mmol), N,N-diethyl-2-phenyl-2-piperazin-1-yl-acetamide (0.23 g, 0.82 mmol), Pd2(dba)3 (0.01 g, 0.0075 mmol), XPhos (0.01 g, 0.015 mmol), and sodium t-butoxide (0.11 g, 1.05 mmol) in toluene (2 mL) was irradiated by microwave at 120° C. for 20 min. The solution was allowed to cool, filtered through diatomaceous earth, washing with DCM (10 mL). The filtrate was concentrated and the residue was purified by SiO2 column chromatography (2 M NH3 in MeOH:DCM) to provide the title compound (0.07 g, 16%). MS: 571.7. 1H NMR (CDCl3): 7.48-7.46 (m, 2H), 7.38-7.35 (m, 4H), 7.28-7.23 (m, 2H), 7.19-7.15 (m, 4H), 6.90-6.89 (m, 2H), 3.70 (bs, 2H), 3.49-3.40 (m, 6H), 3.31-3.12 (m, 8H), 2.70-2.69 (m, 4H), 1.60-1.59 (m, 3H), 1.10-1.04 (m, 6H).

후처리

  1. temperatureto cool
  2. filtrationfiltered through diatomaceous earth
  3. washwashing with DCM (10 mL)
  4. concentrationThe filtrate was concentrated
  5. customthe residue was purified by SiO2 column chromatography (2 M NH3 in MeOH:DCM)

출처 및 근거

ORD 기록
ord-2b1a036168c742dbbc6a7bf38cef0c6a
출처 데이터셋
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08183239B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트